6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline

Catalog No. :
ACBXGH035
CAS No. :
1936429-80-9
Molecular Formula :
C10H10BrF2N
Molecular Weight :
262.10

IUPAC Name:6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline

6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$82.00Login to see priceIn stockInquiry
5g98%$238.00Login to see priceIn stockInquiry
10g98%$394.00Login to see priceIn stockInquiry
25g98%$787.00Login to see priceIn stockInquiry
100g98%$2805.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline
IUPAC Name6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline
MDL No.MFCD32689499
Molecular FormulaC10H10BrF2N
Molecular Weight262.10
SMILESFC(C1=CC2=C(C=C1Br)CCCN2)F
InChI KeyYSIQFNDARSIHNB-UHFFFAOYSA-N
SynonymQuinoline, 6-bromo-7-(difluoromethyl)-1,2,3,4-tetrahydro-;6-Bromo-7-(difluoromethyl)-1,2,3,4-tetrahydroquinoline
CAS No.1936429-80-9

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H315-H318-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACBXGH035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDBRX351 route compound structure diagram
    ACDBRX3511783624-20-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBXGH035 route product structure diagram
    ACBXGH0351936429-80-9 In Stock
Inquiry

2. ACBXGH035 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBXGH035 route product structure diagram
    ACBXGH0351936429-80-9 In Stock
Inquiry

Comments (0)